Oligonucleotide-Based Therapeutics Conference

Convening industry and health authorities to inform, educate, and share advancements in oligonucleotide-based therapeutic product development.

Registrarse

Early Bird Ends

DAYS

HOURS

MINUTES

SECONDS

Volver a Agenda

Session 11: Closing Plenary

Session Chair(s)

René Thürmer

Deputy Head of the Unit Pharmaceutical Biotechnology BfArM, Federal Institute for Drugs and Medical Devices, Germany

This session will allow open discussion between the audience and an esteemed panel of experts to ask any remaining questions. Please note: due to the high volume of questions, not all will be answered live at the conference

¿Tiene una cuenta?